Standard Chartered CEO Apologizes for Lower Value Human Capital Remark LIC Posts Record Quarterly Profit Leading Financial Sector in Q4 Performance BJs Wholesale Club Q1 Earnings Call Highlights Key Takeaways From Management Discussions Automation Threatens 69 of Jobs in India World Bank Data Suggests SK Hynix Crosses 1 Trillion Market Cap as AI Boom Fuels Chip Rally Fresh US Strikes Complicate Iran Deal Geopolitical Risk Resurfaces DHCNI Q1 2026 Earnings EPS Misses Expectations Amid Challenging Real Estate Market Core Main Inc CNM Q1 2026 Earnings EPS Smashes Estimates as Infrastructure Demand Holds Steady Proficient Auto Logistics Inc PAL Q1 2026 Earnings Massive EPS Surprise as Company Beats Negative Estimate by Over 12000 RAND Q1 2026 Earnings Reported EPS of 018 Stock Falls 313 Rapid7 RPD Q1 2026 Earnings EPS Surges Past Estimates as Cybersecurity Demand Remains Strong Contineum Therapeutics CTNM Declines 355 Testing Key Support at 1317 Applovin Corporation APP Edges Lower Amid Consolidation Key Levels in Focus Vera Therapeutics VERA Edges Lower as Stock Consolidates Near Key Resistance Level Biomea Fusion BMEA Stages a Rebound Testing Key Resistance After a 365 Gain Kevin Warshs Potential Fed Overhaul Could Reshape Wall Streets Market Plumbing Trump Pressures Bank of America and JPMorgan Over Alleged Conservative Discrimination Standard Chartered CEO Apologizes for Lower Value Human Capital Remark JPMorgans Summer Reading List for HighNetWorth Clients Highlights AI Leadership and Unconventional Themes Rigetti RGTI Surges 48 Following 100 Million Government Backing Analysts Express Mixed Views on Tech Stocks ServiceTitan Applied Digital and Elastic April US Payrolls Surge Past Expectations Yet Underlying Red Flags Emerge KLAR Q1 2026 Earnings NarrowerthanExpected Loss Drives Stock Higher BlackRock Inc BLK Rises Modestly Holding Near Key Support as Market Sentiment Shifts Pimco Corporate Income Opportunity Fund PTY Edges Lower as Market Sentiment Remains Cautious Grupo Cibest CIB Slips Amid Cautious Trading Key Levels in Focus Vivos Therapeutics Inc VVOS Rebounds Analyzing the 431 Gain and Key Levels Keros Therapeutics KROS Rises 196 Testing Key Resistance at 1202 Toast Inc TOST Rises 521 as Positive Momentum Builds Toward Key Resistance FACT II Acquisition Corp FACT Holds Steady Near Trust Value Amid Quiet Trading